![]() | Yahoo! Health - My Alerts - Edit Alert |
Tuesday, Feb 19, 2013 07:11 PM EST | |
Mom raises money for trained dogs to watch over diabetic girls Tue, 19 Feb, 2013 02:15 PM PST Two young sisters with Type 1 diabetes are raising money for special dogs that will alert them when their blood sugar is running dangerously high or low. Jay Cutler Sending Diabetic Kids to Camp Tue, 19 Feb, 2013 01:58 PM PST Jay Cutler's struggle with diabetes has been a huge part of his growth a quarterback in the NFL. He was diagnosed with Type 1 diabetes when he was 25. Once he learned to handle the disease, Cutler's... Photo Credit: Getty Images Actos Lawsuit News: Rottenstein Law Group Comments on First Trial for the Cancer-Linked Diabetes Drug Tue, 19 Feb, 2013 01:29 PM PST The Rottenstein Law Group, which represents clients in Actos bladder cancer lawsuits nationwide, will monitor the progress of the first Actos trial, which is taking place in Los Angeles. Plaintiff Jack Cooper, 69, alleges that manufacturer Takeda Pharmaceutical failed to warn of the potential risk of bladder cancer and other side effects associated with the use of the drug. (PRWeb February 19 ... Independent panel to present findings on diagnosing gestational diabetes mellitus Tue, 19 Feb, 2013 01:01 PM PST Gestational diabetes mellitus (GDM) is a condition in which women without previously diagnosed diabetes exhibit high blood glucose levels during pregnancy (especially during the third trimester of pregnancy). Actos Lawsuit Update: Bernstein Liebhard LLP Closely Monitoring Nation’s First Actos Bladder Cancer Trial prweb.com Tue, 19 Feb, 2013 12:56 PM PST The Firm continues to evaluate potential Actos lawsuits on behalf of patients who developed bladder cancer, allegedly due to long-term use of Actos.New York, New York (PRWEB) February 19, 2013 The first Actos lawsuit involving allegations that the type 2 diabetes drug caused bladder cancer is scheduled to begin today in Los Angeles Superior Court, Bernstein Liebhard LLP reports. The Firm will ... | |
|
No comments:
Post a Comment